Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial

By afschroeder • May 2, 2026

Martínez E, Watanabe M, Hoffman R, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Sponseller CA, Lu AB, Lu MT, Aberg JA, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK; REPRIEVE Investigators. Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial. Lancet HIV. 2026 May;13(5):e327-e337. doi: 10.1016/S2352-3018(26)00036-6. PMID: 42067280.

Tags: Cardiology/Epi, Infectious Diseases, Publications

Initial Diuretic Strategy During Hospitalization for Heart Failure and Associated Outcomes: Insights from the TREAT-AHF Registry

Varshney AS, Ambrosy AP, Furst A, Zheng J, Bhatt AS, Lala A, Fonarow GC, Fudim M, Greene SJ, Collins SP, Testani JM, Sandhu AT. Initial[...]

Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection

Sahlool Y, Khoury F, Akhondi A. Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection. Cureus. 2026 Jul 7;18(7):e112218. doi: 10.7759/cureus.112218. PMID:[...]

Proteomic Mediators of Chronic Obstructive Pulmonary Disease Phenotypes and Coronary Artery Calcification Burden in Ever Smokers

Abbasi A, Ahmad K, Pratte KA, Moore J, DeMeo DL, Manubolu VS, Kinninger A, Tiller NB, Bowler RP, Budoff M, Casaburi R, Rossiter HB. Proteomic[...]